Literature DB >> 1618794

Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain.

Y Hirabayashi1, T Nakao, F Irie, V P Whittaker, K Kon, S Ando.   

Abstract

A new ganglioside antigen, termed Chol-1 alpha-b, recognized by cholinergic neuron-specific antibody, Chol-1 alpha, was isolated from bovine brain ganglioside mixture using Q-Sepharose. The yield was approximately 1.3 mg from 5 g of the total ganglioside. The chemical structure was characterized as a novel ganglioside by means of gas-liquid chromatography, a permethylation study, mild acid hydrolysis, thin layer chromatography-enzyme immunostaining, fast atom bombardment mass spectrometry, and proton nuclear magnetic resonance spectroscopy. The ganglioside has the following unique structure. [formula: see text] When examined by thin layer chromatography immunostaining and enzyme-linked immunosorbant assays, this ganglioside has the most intense immunoreactivity with Chol-1 alpha antibody among bovine brain gangliosides. As combined with our previous results (Hirabayashi, Y., Hyogo, A., Nakao, T., Tsuchiya, K., Suzuki, Y., Matsumoto, M., Kon, K., and Ando, S. (1990) J. Biol. Chem. 265, 8144-8151; Ando, S., Hirabayashi, Y., Kon, K., Inagaki, F., Tate, S., and Whittaker, X. (1992) J. Biochem. (Tokyo), 111, 287-290), the present study indicates the occurrence of a new series of gangliosides containing N-acetylneuraminic acid residue attaching to N-acetylgalactosamine as cholinergic specific antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Total synthesis of a cholinergic neuron-specific ganglioside GT1a alpha: a high affinity ligand for myelin-associated glycoprotein (MAG).

Authors:  H Ito; H Ishida; H Waki; S Ando; M Kiso
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

Review 2.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

3.  Structure of the main ganglioside from the brain of Xenopus laevis.

Authors:  Angela Maria Rizzo; Bruno Berra; Federica Rossi; Anna Guerra; Rosalba Gornati; Giovanni Bernardini; Takao Taki; Takeshi Kasama; Laura Mauri; Sandro Sonnino
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 4.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 5.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

6.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 7.  Cholinergic-specific glycoconjugates.

Authors:  V P Whittaker; S Kelić
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

8.  A novel ganglioside with a free amino group in bovine brain.

Authors:  K I Hidari; F Irie; M Suzuki; K Kon; S Ando; Y Hirabayashi
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

9.  Synaptic function of cholinergic-specific Chol-1alpha ganglioside.

Authors:  Susumu Ando; Yasukazu Tanaka; Satoru Kobayashi; Fumiko Fukui; Machiko Iwamoto; Hatsue Waki; Tadashi Tai; Yoshio Hirabayashi
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

10.  Gangliosides are neuronal ligands for myelin-associated glycoprotein.

Authors:  L J Yang; C B Zeller; N L Shaper; M Kiso; A Hasegawa; R E Shapiro; R L Schnaar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.